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Abstract: Subcutaneously implanted experimental tumors in mice are commonly used in 
cancer research. Despite their superficial location, they remain a challenge to image non-
invasively at sufficient spatial resolution for microvascular studies. Here we evaluate the 
capabilities of optical coherence tomography (OCT) angiography for imaging such tumors 
directly through the murine skin in-vivo. Datasets were collected from mouse tumors derived 
from fibrosarcoma cells genetically engineered to express only single splice variant isoforms 
of vascular endothelial growth factor A (VEGF); either VEGF120 or VEGF188 (fs120 and 
fs188 tumors respectively). Measured vessel diameter was found to be significantly (p<0.001) 
higher for fs120 tumors ȝP FRPSDUHG WR fs188 tumors ȝP The fs120 
tumors also displayed significantly higher vessel tortuosity, fractal dimension and density. The 
ability to differentiate between tumor types with OCT suggests that the visible abnormal 
vasculature is representative of the tumor microcirculation, providing a robust, non-invasive 
method for observing the longitudinal dynamics of the subcutaneous tumor microcirculation. 
© 2017 Optical Society of America 
OCIS codes: (170.3880) Medical and biological imaging; (110.4500) Optical coherence tomography; (170.2655) 
Functional monitoring and imaging; (100.2000) Digital image processing. 
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1. Introduction 
Within the body, the structural features of major arteries and veins are genetically controlled 
during embryonic development and generally remain consistent between individuals. The 
microvasculature however can be dynamically remodeled as a result of molecular and 
mechanical stimuli within the local microenvironment[1]. Tumor growth relies on a continual 
process of micro-vascularization, notably via angiogenesis, which also facilitates metastasis[2]. 
The resulting tumor vasculature is both morphologically and functionally abnormal[3], the 
study of which potentially offers valuable insight into tumor development and pathophysiology. 
Angiographic imaging of murine models of cancer has proved particularly important to 
oncological research, greatly aiding our understanding of tumor growth, progression and 
treatment within living animals[4]. Traditional necropsy methods such as 
immunohistochemistry have retained their importance for quantifying the microcirculation 
within implanted tumors[5]. However modern non-invasive imaging techniques have quickly 
gained traction due to the potential of longitudinal vascular visualization, vastly reducing the 
number of animals required to produce statistically robust data. Currently, intravital microscopy 
is widely utilized to study tumor growth, typically involving the surgical replacement of the 
highly scattering skin layer with a transparent glass coverslip[6]. Using this model, 
angiographic optical coherence tomography (OCT) imaging has been used to enable high-
resolution longitudinal imaging of tumor dynamics and response to treatment[7]. Furthermore, 
in-vivo full field angiography of subcutaneously grown tumors, with overlying skin intact, has 
previously been achieved with perfusion computed tomography[8] and dynamic magnetic 
resonance imaging[9], [10]. More recently, multi-spectral optoacoustic tomography has been 
utilized to visualize YDVFXODUPRUSKRORJ\DQGR[\JHQDWLRQDWȝP resolution over entire 1cm3 
tumor volumes[11].  
Despite these advances, it remains challenging to non-invasively image the microscale 
circulation within subcutaneously implanted tumors because optical modalities are required to 
resolve these vessels (typically 5-ȝPLQGLDPHWHU[12]), and these modalities are often unable 
to penetrate through the highly scattering layer of skin. OCT is an established imaging 
technique which has been widely utilized to capture both structural and angiographic images 
within human skin[13]. Most notably, OCT offers depth penetration of up to ~1mm within 
tissue and is capable of extracting depth encoded data such that individual layers of tissue can 
be visualized at a high resolution. Compared to human skin, which can be many millimeters 
thick; female CD-1 nude mice generally exhibit superficial tissue layers approximately ~5ȝP
LQWKLFNQHVVaȝPHSLGHUPLVaȝPGHUPLVa3ȝPK\SRGHUPLV[14]; thus the superficial 
vasculature of subcutaneously implanted tumors may be visible and within the field of view of 
OCT. Speckle-variance OCT (svOCT) can be used to extract volumetric flow information from 
four-dimensional OCT data sets (X-Y-Z-Time), with multiple data points being collected at 
each spatial location[15]. This is based on the fact that a fluid pixel will display rapidly evolving 
temporal variations in the OCT signal (speckle patterns) when compared to solid tissue pixels. 
Hence by calculating the variance of pixels at the same spatial location as a function of time, 
contrast is generated between stationary solids and moving liquids.  
This study aimed to develop and evaluate the performance of angiographic svOCT in the 
context of murine subcutaneous tumor imaging. In particular, we attempt to differentiate the 
vascular morphologies within mouse tumors derived from fibrosarcoma cells genetically 
engineered to express only single splice variant isoforms of vascular endothelial growth factor 
A (VEGF); either VEGF120 or VEGF188 (fs120 and fs188 tumors respectively). Previously, 
using tumors grown in transparent chambers implanted into the rear dorsum of mice and 
conventional intravital optical microscopy, we observed that fs120 tumor blood vessels were 
larger, more disorganized and formed more tortuous vascular networks than those of fs188 
tumors[16]. This study aimed to identify whether these differential vascular patterns were also 
present within the microcirculation of subcutaneously grown tumors, independent of the dorsal 
skin-fold window chamber. 
 
2. Materials and methods 
All animal experiments were conducted according to the United Kingdom Animals (Scientific 
Procedures) Act 1986 (UK Home Office Project License PPL40/3649) and with local 
University of Sheffield ethical approval. 
2.1 Subcutaneous tumor implantation 
In order to evaluate the capabilities of OCT for the imaging of subcutaneously implanted 
tumors, mouse fibrosarcoma tumor cells (1x106 in 0.05 ml serum-IUHH 'XOEHFFR¶V 0LQLPDO
Essential Medium) expressing VEGF as only its highly soluble VEGF120 isoform (fs120 tumor 
cells) or its highly matrix-bound isoform VEGF188 (fs188 tumor cells) were subcutaneously 
injected into the rear dorsum of female CD1 nude mice aged 8-12 weeks. Development of these 
cell lines has been described previously[16]. Female nude mice were chosen due to their 
absence of hair, and having slightly thinner dermis/hypodermis skin layers than male nude 
mice[14]. OCT imaging of each tumor was performed daily, with the mice under isoflurane 
anesthesia. Daily caliper measurements were made of the three orthogonal tumor diameters and 
animals were sacrificed once the largest tumor diameter reached no more than 12mm. Excised 
tumors with overlying skin intact were halved and fixed in 10% neutral buffered formalin 
overnight and then paraffin-embedded prior to processing for histological analysis with 
hematoxylin and eosin (H&E) staining and immunohistochemistry for rat anti-mouse cluster of 
differentiation 31 (CD31) monoclonal antibodies (Cat No. DIA-310, Dianova GmbH, 
Hamburg, Germany), as a marker of vascular endothelial cells.  
2.2 Data acquisition and imaging protocol 
All imaging for this study was performed using a commercial CE-marked multi-beam OCT 
system (Vivosight®, Michelson Diagnostics Ltd, Orpington, Kent, UK). This system utilizes a 
swept-source 1305nm Axsun laser with a bandwidth of 147nm, achieving a resolution of 
approximately 5ȝP D[LDOO\ DQG ȝP ODWHUDOO\ (In tissue). One-dimensional A-scans are 
captured at a line rate of 20 kHz and contain structural information to a depth of approximately 
1mm in murine skin. The imaging beam is scanned laterally across the surface of the tumor in 
order to collect a 3-dimensional image. In an effort to reduce the degree of motion within the 
collected OCT scans, the mobile imaging probe of the Vivosight was clamped into position and 
manually lowered to the correct height. A plastic standoff bridged the gap between the imaging 
probe and the skin. The standoff gently contacted the skin surface such that any lateral 
movement was reduced. Fixation of the imaging probe in this manner is important as it removes 
a source of movement from the resulting data. In order to minimize homeostatic effects on the 
circulation as a result of temperature variation, the rectal temperature of the mouse was 
maintained at 37°C during imaging using a heating mat which was thermostatically controlled 
via a rectal thermocouple probe. Furthermore, all imaging was conducted inside a plastic 
chamber which was heated to an internal temperature of 32°C. This experimental setup is 
illustrated in fig. 1. 
 
Fig. 1. Experimental setup within a plastic chamber which was heated to 32°C internal 
temperature. A) Rodent facemask for administration of isoflurane gaseous anesthesia. B) CD-1 
Nude mouse. C) Plastic standoff which gently contacts the skin around the subcutaneous tumor. 
D) The OCT imaging probe (Vivosight). E) Feedback controlled heated mat. F) Rectal 
temperature probe (Feeds back to the heated mat). G) Mobile clamp for repositioning of the OCT 
imaging probe.  
 
For this study, the scan size was set at 6mm in both the x and y directions, giving a wide 
field of view across the tumor. The spacing between A-scans was fixed at ȝPin order to 
closely match the lateral resolution of the OCT system while maintaining a high scan speed. 
Five repeat frames (ܰ ൌ ͷ) were collected at each stepped y-location and later used to evaluate 
the speckle-variance within each voxel. With these settings, each dataset took approximately 
90 seconds to acquire, the raw data was stored to disk and processed offline. 
2.3 Post-processing of data 
Following data acquisition, data processing was performed externally within MATLAB 
(R2015b ± MathWorks). To minimize processing time, each stack of B-scans was processed in 
parallel using a graphical processing unit (GPU) (NVIDIA GeForce GTX 780) with 4GBytes 
of RAM. This was achieved through utilization of the parallel computing toolbox within 
MATLAB.  
Directly following the resampling of raw OCT data into image space there are numerous 
post processing steps that were performed in order to maximize the contrast of the svOCT 
images and reduce the influence of motion artefacts on the resulting visualization. Firstly, a 
sub-pixel accurate image registration algorithm was applied in order to register frames within 
each stack (100th of a pixel accuracy). This attenuates unwanted subject movement within the 
B-scan plane. For this, a cross-correlation based algorithm initially described by Guizar et 
al[17] was selected and modified to utilize the GPU's architecture. This algorithm uses a 
selectively upsampled discrete Fourier transform as opposed to a zero-padded fast Fourier 
transform in order to reduce the required computational time and memory without negatively 
affecting the accuracy of registration; this is ideal for GPU computing as memory usage is 
typically a limiting factor. After registration, each repeat frame within the stack (N=5 frames 
at each location) was assigned a score equal to its average correlation to each of the other frames 
within the stack. The frame with the highest score was then assigned as the best candidate for 
a base frame. Following this, the k frames within the stack which exhibit the highest correlation 
with the base frame were retained, with any other frames being discarded. For simplicity, the 
parameter k was defined as half the stack size rounded up, so in the case of 5 repeat frames at 
each location, 3 frames were retained for further processing. This process, repeated across each 
stack of repeat images served to retain a proportion of the data that was least likely to be 
corrupted by motion artefacts without requiring the assignment of a dynamic correlation 
threshold value. These registration techniques are similar to those utilized in previous work[18], 
and are an effective method of reducing motion derived artefacts. 
Following this correlation optimization step, the speckle-variance signal is calculated from 
the remaining 4-dimensional image data using a variance equation adapted from previous work 
by Mariampillai et al[15] (Eq.1). 
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  ¦                   (1) ݔ,ݕ and ݖ correspond to voxel indices, ݊ represents the frame index within each B-scan 
stack and ܫ is the corresponding pixel intensity at a particular spatial location. The 1D median 
function is performed across each stack (n=1:k) and serves to attenuate outlier values of 
variance, such as those caused by sudden interface movements.  
A thresholding process was then performed to remove noise-dominated areas containing 
little to no information regarding the structural properties of the tissue. For this, each stack of 
B-scans was averaged and 2D Gaussian filtered with kernel size 5x5 and a standard deviation 
of 2 pixels. A mask was then generated through binary segmentation of the resulting images, 
with the threshold being defined as the 95th percentile of pixel intensities situated within the 10 
deepest image rows. The lower rows were selected as they typically exhibit close to zero 
structural signal, instead consisting entirely of noise. This mask was applied to the 
corresponding svOCT image, deleting areas that contained negligible OCT signal.  
The next step involved flattening the skin surface level such that vascular plexus could be 
projected onto a flat horizontal plane. This is required as the murine skin is very rarely flat on 
the surface, instead consisting of various epidermal ridges. Noise and bright artefacts 
originating at the interface between the stratum corneum and air make it challenging to 
accurately segment the surface of the skin. Hence surface detection was achieved using the 
averaged B-scans that were previously used for thresholding purposes. For this, a mask was 
generated by considering the differential between pixels in the depth (z) direction of the B-scan 
images; highlighting only regions with a significant increase (dark to bright) in intensity. 
Morphological area opening was then applied to this mask to remove any detected regions 
which were below 50 pixels in size. The most superficial detections for each column (z) were 
recorded and any gaps in the resulting surface line were interpolated across (cubic-spline). This 
process was repeated for each of the B-scan stacks, with the 2D surface detections being 
combined to produce a 3D surface plot.  Lastly the detected surface was 2D median filtered 
with a 20x20 kernel to eliminate outliers and then used to axially shift each A-scan of the 
svOCT data to a certain predefined surface depth. 
Despite the previous processing steps, strong vertical motion artefacts remained visible on 
the en-face images of the tumor vasculature. These arise because of global decorrelation caused 
by the animals breathing, heartbeat or muscular spasms during the imaging process. To improve 
visualization of the data and enable accurate quantification of vascular morphology to be 
performed, it was necessary to remove these artefacts. Previous publications have utilized 
consecutively acquired 3D volumes and vessel layer segmentation in order to mosaic and 
eliminate such vertical bands with no notable image degradation[18], providing they are at a 
different location on each consecutive scan. However, to avoid doubling the required scan time 
for each volume, these bands were instead removed entirely through software. This was 
achieved using a combined wavelet-FFT filter similar to that previously described[19]. Briefly, 
the filter attenuates high frequency components along the y-direction of the OCT volume, 
notably the sharp decorrelations caused by movement, which result in similarly sharp spikes in 
svOCT image intensity. Such vertical components are separated from the underlying detailed 
image using a multi-level Daubechies wavelet transform (DFK ³YHUWLFDO´ LPDJH from the 
wavelet decomposition was then 2D Fourier transformed and the central frequencies 
surrounding the x-axis were attenuated through application of a 11-pixel high mask, designed 
to remove non-uniform (in y) vertical line artefacts. The vertical image is then inverse Fourier 
transformed and reFRPELQHG ZLWK LWV FRUUHVSRQGLQJ ³KRUL]RQWDO´DQG ³GHWDLO´ LPages using 
successive inverse wavelet transforms. While removal of perfect vertical artefacts is achievable 
simply using the Fourier transform, the additional wavelet transformations allowed for 
imperfect artefacts to be removed with minimal effect on the underlying detail. Fig. 2 shows 
the result of wavelet filtering on the vasculature of an fs188 tumor. Since the vertical lines are 
effectively being blurred in the y-direction (due to the attenuation of high frequency y-
components in the image), this process can result in visible banding within the background 
intensity of the image, particularly around areas which contained wide or numerous line 
artefacts. Despite these banding artefacts, the underlying image clarity was greatly improved 
and binarization was able to be performed without the anomalous detection of the strong 
vertical lines (Sec. 2.4). 
 
 
Fig. 2. En-face svOCT images of an fs188 tumor before (Left) and after (Right) wavelet/FFT 
filtering was performed using a Daubechies wavelet to a decomposition level of 5. The colors 
correspond to the depth of the detected vessels, red vessels are 0-300ȝP and green vessels are 
300-600ȝPEHQHDWKWKHVNLQVXUIDFH 
 
Following post-processing, as described above, the resulting SV matrix contains 3-
dimensional information pertaining to the location of the microvasculature.  
2.4 Quantification of vessel parameters 
Quantification of vessel parameters required binarization of each angiographic image such that 
a vascular skeleton could be generated. For this, volume projections of the OCT datasets were 
generated by performing a mean-intensity projection (MIP) over the depth range 0-800ȝP. The 
resulting angiographic OCT images were often noisy, with both vessels and background being 
highly non-uniform in pixel intensity (fig. 3B). As a result of this, simple intensity thresholds 
are challenging to assign, generally yielding an overly complex skeleton with noise being 
anomalously detected as vasculature. To address this issue, the images were median filtered 
with a 3x3 kernel before being processed with a multiscale Hessian filtering algorithm[20]. 
7KLVDOJRULWKPDWWHPSWV WRPHDVXUHWKH³YHVVHOQHVV´RIDSL[HOWKURXJKFRQVLGHUDWLRQRI WKH
eigenvalues of the local Hessian matrix, assigning a value close to 1 for regions which are 
tubular in nature and 0 for regions which remain flat. To minimize any artificial vessel dilation 
or constriction in the resulting image it was necessary to repeat this process over a range of 
vessel scales (5-ȝPZLWKWKHPD[LPXPILOWHUYDOXHfor each pixel being recorded (fig. 3C). 
The filtered image was then pixel-wise multiplied by the original image to suppress the 
background noise and improve contrast (fig. 3D). This combined image was then binarized 
using an automatically defined Otsu threshold[21] before being skeletonized (fig. 3E/F).  
 
 
Fig. 3. Processing steps for the quantification of svOCT data. A) En-face svOCT image captured 
from a subcutaneous fs-120 tumor 17 days post-implantation. Dashed box shows zoomed section 
from B-G. B) Zoomed section of the en-face svOCT image. C) The result of the hessian-based 
filtering algorithm. D) The result of B*C, improved vascular contrast against the background. 
E) Binary threshold in green overlaid on the original image. F) Skeleton in blue overlaid on the 
original image. G) Map of vessel diameter calculated using the binary threshold and the skeleton 
data from E and F. 
 
A user defined field-of-view was used for quantification to ensure that only representative 
areas were selected. Areas of expected low angiographic signal such as the corners or 
gaps/holes in the image were discarded. Using the skeleton and binary data, vessel diameter 
was defined at each point on the skeleton as width of the binarized data perpendicular to the 
skeleton, a mean vessel diameter was then calculated by averaging across all skeleton points 
within the field-of-view. Total vessel length per mm2 was calculated by averaging the total 
length of skeleton contained within 1mm2 sub-blocks of the image. Vessel density (%) was 
simply the percentage of pixels within the field-of-view that were identified as vascular. 
Tortuosity was calculated as the average ratio between shortest path length and Euclidean 
distance between distant end-points at opposite sides of the skeleton. To calculate vessel 
segment length, the skeleton was broken into vessel segments by removing bifurcation points 
from the network, segment length was then defined as the path length between segment end 
points. Lastly, the fractal dimension of the skeleton was calculated using the box-counting 
method, resulting in a value between 0 and 3, with lower values indicating a more regular 
network[22]. 
For the longitudinal comparison of svOCT images captured from the same tumor over a 
period of time (Section 3.2), elastic image registration was performed in order to ensure 
accurate vessel correlation between frames. This was achieved using a vector-spline method 
which has been detailed previously[23]. 
 
2.5 Statistics 
Statistical analysis was carried out using MATLAB (R2014b ± Mathworks). The unpaired 
Students t-test was used to test for significant differences between the two tumor types (fs188 
and fs120). For cases where comparisons were made between three groups (Healthy, fs188 and 
fs120) a one-way ANOVA followed by the Tukey-Kramer honest significance difference 
(HSD) test was used. In all cases, comparisons were described as significant if the probability 
of the null hypothesis was <0.05. All stated measurements are of the form mean±SD. 
 
3. Results and discussion 
3.1 Visual inspection of VEGF120 and 188 expressing tumors 
Fig. 4 shows a selection of en-face depth encoded svOCT images captured from both baseline 
skin and the subcutaneously implanted tumors of CD1 nude mice. 
 
Fig. 4. A selection of 6x6mm en-face svOCT images. A-D) Images of baseline murine skin 
vasculature without the presence of a tumor. E-L) Images of established subcutaneous tumor 
vasculature, each image is of a separate tumor captured once the largest tumor diameter exceeded 
10mm. Middle row (E-H) shows tumors expressing only the VEGF120 isoform (fs120) and 
bottom row (I-L) shows tumors expressing only the VEGF188 isoform (fs188). All images were 
captured from different animals. The colors correspond to the depth of the detected vessels, red 
vessels are 0-4ȝP and green vessels are 400-8ȝPEHQHDWKWKHVNLQVXUIDFHE-L) Number 
of days post-implantation > 14 days.  
 
The large abnormal vessel networks such as those seen in fig. 4E-L only became visible to 
svOCT approximately 8-15 days post implantation. Prior to this, more regular organized vessel 
networks as represented in fig. 4A-D were visible. This suggests that the early stages of tumor 
vessel development remain too deep within the tissue to be effectively imaged by OCT. 
However, after sufficient tumor expansion, typically ~10-days post-implantation, large 
abnormal vessels were clearly visible within the field-of-view of the OCT system. This 
longitudinal vascular growth is further discussed in section 3.2. Interestingly, the baseline 
vasculature appeared to be absent from the late-stage scans as evidenced by a comparatively 
ORZHU DQJLRJUDSKLF VLJQDODW WKH ³UHG GHSWK´ -400ȝP) aside from that attributed to larger 
abnormal vessels, suggesting that as the skin stretches over the surface of the tumor the flow in 
regular vessels ceases.  Furthermore, it appears that the fs120 tumors are more infiltrative than 
the fs188 variants, with a large portion of abnormal vessels appearing at superficial depths 
within skin. This is clearly visible in fig. 4, where a large portion of the fs120 vessels appear 
red (0-400ȝPGHSWK, whereas the majority of the fs188 vessels appear green (400-800ȝP
This effect may be related to the distinct phenotype of the fibrosarcoma cells, with fs120 cells 
demonstrating a more proliferative phenotype than the fs188 variants both in-vitro and in-vivo. 
Furthermore, fs120 tumors have an additional ability to adopt both mesenchymal and amoeboid 
morphologies, which is considered an advantage for invasion[24]. One limitation of the svOCT 
technique is an observed shadowing effect beneath detected vessels caused by the forward 
scattering of photons by blood, which can occlude underlying vasculature[7]. For the case of 
the fs120 tumors, many of the vessels which are likely to be at the 400-800ȝP depth range 
(Green) are occluded by more superficial vessels at the 0-400ȝP depth range (Red), making 
vessels density calculations challenging to perform at an equivalent depth. This limitation is 
discussed further in section 3.3. 
 
3.2 Evaluation of longitudinal tumor monitoring 
One key advantage of non-invasive subcutaneous tumor imaging is the potential for 
longitudinal observation of tumor growth and vascular development. Fig. 5 shows an example 
of longitudinal data acquisition, with images being acquired from the same fs120 and fs188 
tumors over a period of 5 days, as well as a longer timescale visualization of vascular 
development within an fs188 tumour from days 0 to 15. 
 
 Figure 5. Top and middle rows) Depth encoded short-term longitudinal svOCT images of both 
an fs120 and an fs188 tumor over a period of 5 days. Images have been elastically registered 
together using UnwarpJ[23] such that the same vessels align on subsequent frames. Bottom row) 
4x4mm (Zoomed) en-face svOCT images showing long-term longitudinal vascular progression 
from pre- tumor implantation to 15-days post- tumor implantation. Each separate row represents 
longitudinal data that was captured from one unique animal. The colors correspond to the depth 
of the detected vessels, red vessels are 0-4ȝPDQGgreen vessels are 400-8ȝPEHQHDWKWKH
skin surface. The white number in the lower left corner of each image corresponds to the number 
of days post-tumor implantation that the image was captured. 
 
The scans have been elastically co-registered such that vessels are aligned, following a similar 
methodology to that detailed previously[18]. For the case of the fs120 tumor, the mean vessel 
length per mm2 is highest at day 14 post-implantation (4.1mm-1), it then decreases to 1.4mm-1 
at day 15, recovers to 3.5mm-1 on day 17 before decreasing again to 2.1mm-1 on day 18. 
Comparatively the fs188 tumor rises from 1.1mm-1 on day 14 (excluding the lower region 
which was outside of the scan field-of-view), to 2.2mm-1 on day 15, reduces to 2.0mm-1 on day 
17, before returning to 2.2mm-1 at day 18. To investigate this effect over a larger sample size, 
the standard deviation of mean vessel length per mm2 was calculated for each tumor within 
both the fs120 and fs188 cohorts over days 14 to 18 post-implantation. A two-sample 
independent t-test was then used to evaluate significance. A majority of the tumors had 
unsuitable datasets and thus were omitted from this analysis. Omission was a result of either 
the data having a non-complimentary field of view (non-overlapping scan site on subsequent 
days), or certain days displaying motion corrupted vascular signal, both being unsuitable for 
comparison. In total, the number of viable datasets used was n=4 for both the fs120 and fs188 
groups. Whilst the fs120 group had a higher variation in measured vessel lengths over time (SD 
= 1.4mm-1) when compared to the fs188 group (SD = 0.4mm-1), this result did not reach 
statistical significance (p=0.063) due to the small sample number. Thus it is unclear if fs120 
tumors demonstrate increased day-day variation in mean vessel length. Fig. 6 shows the 
changes in mean vessel length per mm2 for each animal over time. 
 
 
Fig. 6. Line plots showing the variation in measured vessel length per square mm as a function 
of time within subcutaneous tumors expressing either the VEGF120 isoform (blue) or the 
VEGF188 isoform (red). The standard deviation in the measured mean vessel length for each 
animal is calculated as a function of time, and represents how much variance is visible within 
the measurement. The average of these standard deviations across all four fs120 mice  
(1.4mm-1) is higher than those in the fs188 cohort (0.4mm-1), however this result does not reach 
statistical significance (p = 0.063). 
 
Such variability in the number of visible vessels from one day to the next is unlikely to be 
a result of vascular remodeling. It could potentially be a direct result of increased pressure being 
applied to the surface by the plastic standoff cap on these days (Seen in fig. 1C). However, in 
this case the more superficial (red) vessels might be expected to occlude, which does not appear 
to be the case. Alternatively, it is possible that reduced localized flow within the disappearing 
vessel linkages is responsible for the loss of visualization, as if the decorrelation time of the 
slow-flowing blood reduces below the frame acquisition interval (~30ms) of the OCT system, 
then the flow signal is lost. Another explanation for the loss of vessel density is that 
vasoconstriction or upstream vascular shunting may be occurring as the region homeostatically 
responds to small changes in external stimuli such as temperature. It is also highly likely that 
the use of isoflurane anaesthetic is both influencing the degree of thermoregulatory inhibition 
and acting as a cardiovascular depressant, reducing the blood pressure [25], [26]. For this study, 
given the relatively low volume acquisition rate of the Vivosight OCT system (0.01 Hz), it was 
not feasible to perform angiographic imaging of solid tumors without the use of anaesthetic. 
Recent developments in MHz range swept source lasers have enabled angiographic OCT 
volume scans to be acquired at video rate (1-25 Hz)[27], [28]. This may enable high-speed 
imaging of the subcutaneous tumor microcirculation without the requirement of anesthetic. 
 
3.3 Evaluation of OCT depth penetration 
Fig. 7 shows a direct comparison between the OCT B-scans and histological samples taken 
from the rear-dorsum of CD1 nude mice. In healthy skin (fig. 7A/B) a thick hypodermis layer 
(~400ȝP) is filled with dense hair follicles which scatter the incident 1300nm OCT beam, 
preventing the light from penetrating deeper into the tissue. A thin section of the striated muscle 
layer is visible to the right side of the OCT image, but structures are not discernable beneath 
this layer.  
 
 Fig. 7. Comparing the depth penetration of OCT against histological sections of murine rear-
dorsum skin. A) H&E stained section of healthy skin. B) OCT B-scan of healthy skin (Different 
animal to A). C) H&E stained section of the skin above an fs120 tumor, showing the lack of the 
muscular layer. D) OCT B-scan of the skin above an fs120 tumor (Same animal as C). E) H&E 
stained section of skin with an fs188 tumor visible beneath the muscular (panniculus carnosus) 
layer of the skin. F) OCT B-scan of the skin above an fs188 tumor (Same animal as E). 
 
While the thickness of the hypodermis within murine skin is known to be modulated by the hair 
cycle[29], the presence of a tumor has clearly altered the outer skin morphology (fig. 7C/E). 
To investigate this, multiple measurements of the hypodermal thickness were acquired from 
sections of skin. Given the variable contrast of the hypodermis on the cross-sectional OCT 
images, particularly for the fs120 tumors (fig. 7D), these measurements were made using 
histological sections of the skin. For each unique skin section, the upper and lower layer of the 
hypodermis were manually traced within MATLAB (R2015b ± MathWorks), an average value 
of hypodermis thickness was then calculated by considering the vertical distance between these 
upper and lower boundaries. These measurements of hypodermis thickness were acquired from 
healthy skin (n=7) and compared to similar measurements acquired from skin surrounding the 
fs188 and fs120 tumors at the end of the study (n=7 per group). A balanced one-way ANOVA 
was performed between the three groups, followed by the Tukey-Kramer HSD test to evaluate 
significance, these results are summarized in fig. 8.  
 
 Fig. 8. Variation in the thickness of the hypodermis (fat) layer within healthy skin compared to 
that of the skin encapsulating ~12mm diameter fs188 and fs120 tumors. The fatty layer is 
significantly thicker in healthy skin than both fs188 and fs120 skin, furthermore this layer is also 
significantly thicker in fs188 skin than fs120 skin. A thicker fat layer appears to correlate with 
an increase in the number of hair follicles present, reducing the depth penetration of the OCT 
imaging beam. (columns, mean; bars, standard deviation; crosses, datapoints). All groups 
contain n=7 samples, significance calculated using a one-way ANOVA followed by a Tukey-
Kramer HSD test. 
 
The thickness of the hypodermis was found to be significantly greater in healthy skin 
(357±94ȝP) compared to that of skin covering an fs188 tumor (182±62ȝP, p<0.01) or fs120 
tumor (57±60ȝP, p<0.001). There was also a significant reduction in skin thickness between 
the fs188 and fs120 groups (p=0.015), which could be caused by abnormal strains placed on 
the skin as it stretches over the growing tumor. An example of the thinned hypodermis is seen 
for the fs188 tumor (fig. 7E/F); in these cases OCT is able to capture the upper layers of skin 
(epidermis, dermis), the adipose layer of fat cells (hypodermis), the muscular layer and 
DSSUR[LPDWHO\ ȝP GHHS LQWR WKH fs188 tumor, representing a total depth penetration of 
~1mm. Fig. 7C/D show similar comparisons for an fs120 tumor. Interestingly, most fs120 
tumors exhibited a unique skin morphology in that the layer of striated muscle was absent and 
in some extreme cases the hypodermis was also heavily disrupted, with adipocytes scattered 
within the tumor, there was also a notable absence of hair follicles within the hypodermis (fig. 
7C). This could again be indicative of the more invasive phenotype of this tumor type[24]. In 
such cases, the remaining layers of sXSHUILFLDOVNLQZHUHaȝPWKLFNFRQVLVWLQJRIRQO\WKH
epidermis, dermis and extremely thinned hypodermis. This resulted in a much deeper view into 
the tumor tissue with OCT as seen in fig. 7D, potentially explaining why large abnormal tumor 
vasculature was visible at superficial depths of less than 300ȝP in fig. 4. 
 
 
 Fig. 9. CD31 immunohistochemistry demonstrating the presence of endothelial cells lining the 
vessels within the rear-dorsum skin of CD1 nude mice. A-C) H&E stained serial sections of 
healthy, fs120 and fs188 skin respectively. D-F) CD31 immunostained serial sections of healthy, 
fs120 and fs188 skin respectively. Endothelial cells are stained in brown. Red arrows represent 
the largest visible vessel lumen. Red boxes represent the zoomed sections from G-I. G-I) 
Zoomed view of vessels within the hypodermis of the CD31 stained sections. The fs120 tumor 
shown here was excised 14 days post-implantation and is a different tumor to the one shown in 
figure 9. The fs188 tumor shown here was excised 20 days post-implantation, and is the same 
tumor shown in figure 9.  
 
Fig. 9 shows a comparison between H&E and CD31 stained sections of healthy, fs120 and 
fs188 skin. In the case of healthy skin (fig. 9A/D/G), CD31 immunostaining has highlighted 
the presence of vascular endothelial cells throughout the dermis, hypodermis and striated 
muscle layers of the murine skin. The largest visible vessel lumen, highlighted by the red arrow 
is approximately 15ȝP in diameter. For the skin containing an fs120 tumor (fig. 9B/E/H), the 
majority of vessels are visible at the periphery of the tumor, the largest of which is ~65ȝP in 
diameter (red arrow). For the skin overlying an fs188 tumor (fig. 9C/F/I), there is still evidence 
of vascularization within the dermis/hypodermis, however the majority of visible vessels are 
inside the tumor, directly below the striated muscle layer at a depth of ~600ȝP, the largest of 
which is ~50ȝP in diameter (red arrow). These are likely to be the vessels which appeared 
green on fig. 4. Fs120 tumor cells have clearly invaded deep into the hypodermis, whereas the 
fs188 tumor remains contained beneath the striated muscle layer. Due to the increased 
infiltration of the fs120 tumors, these vessels are situated at a depth of 300ȝP and appear red 
on the depth resolved OCT scans shown in fig. 4. 
 
In general, depth penetration appears sufficient to capture the superficial layers of 
vasculature within both fs120 and fs188 tumors. However, achieving high axial depth 
penetration at a particular location remains dependent on the absence of highly scattering 
structures in the upper skin layers. Shadows from superficial scattering structures such as hair 
follicles can be seen as a banding pattern on fig. 7B/D/F, and may occlude the angiographic 
signal from vessels directly below the structure. 
 
3.4 Quantitative vessel metrics 
Fig. 10 shows the variation of each of the quantitative parameters detailed in section 2.4 as a 
function of tumor type at study endpoint. Independent two-sample t-tests were used to calculate 
significance between the tumor types, with the significance levels between tumor types being 
listed above each graph. Mean vessel diameter was significantly higher for the fs120 tumors 
(60.7±4.9ȝPWKDQWKHfs188 tumors (45.0±4.0ȝP, an observation which agrees with previous 
intravital observations of the same tumor types grown in window-chambers[16]. It is likely that 
measured vessel diameters below 20ȝP are overestimated when viewed through OCT, due in-
part to spatial aliasing. Given that the OCT datasets for this study were acquired with lateral 
VSDFLQJǻ[ǻ\RIȝP1\TXLVWVDPSOLQJsuggests that vessels <20ȝP will be affected by 
aliasing. Indeed, in the context of window-chamber imaging, Vakoc et al demonstrated good 
correlation between multiphoton microscopy and OCT angiograms (Using a mean lateral 
spacing of ~6.3ȝP) for large vessels, however capillaries which were below 12ȝP in diameter 
exhibited poor correlation due to them appearing wider with OCT[7]. Given the qualitatively 
thinner vessel morphologies visible within the fs188 tumors (fig. 4) it is likely that this spatial 
dilation has a larger effect on the mean fs188 vessel diameters than the corresponding fs120 
measurements. However, the differences between tumor types remain significant. 
The total vessel length per mm2 (mm/mm2) was significantly higher for the fs120 tumors 
(4.3±1.5mm-1) than the fs188s (2.2±0.7mm-1). Similarly, a higher overall vessel density was 
measured in the fs120 tumors (31.7±11.1%) compared to the fs188 tumors (14.8±5.0%). These 
observations agree with density calculations performed by CD31 stained vessel counting[30]. 
Interestingly, window-chamber observations yielded a lower total vessel length per mm2 for 
fs120 tumors, the opposite to what is observed here[16]. Its highly likely that such discrepancies 
result from the different depths / quantification methods of the tumor circulation under 
consideration. Indeed, the reduced infiltration of the fs188 tumor vasculature to the more 
superficial layers of skin, as observed in sections 3.1 and 3.3, would directly result in lower 
lengths of overall detected fs188 vasculature, particularly since skeletonization was performed 
on projections over a large 0-800ȝP depth range. It would be useful to compare the observed 
length per mm2 at equivalent depths within the tissue. However, a direct comparison between 
vessel lengths at the green depth of fig. 4 (400-800ȝP) would yield inaccurate results for the 
fs120 tumors because much of the green vasculature is directly occluded due to the shadowing 
artefact cast downwards from the more superficial red vasculature[7]. An alternative is to 
SHUIRUPWKHPHDVXUHPHQWRYHUD VPDOOHUGHSWK³ZLQGRZ´ e.g. by considering only the first 
100ȝP of visible vasculature, decoupled from its axial position within the tissue. To investigate 
this, mean-intensity-projection images were captured over a 100ȝP depth with the superficial 
layer of the projection window placed where the first tumor vasculature was visible. When 
processed in this manner, the fs120 tumors displayed significantly (p=0.04) lower vessel length 
per mm2 (1.5±0.7mm-1) compared to fs188 tumors (2.2±0.3mm-1). However, it remains unclear 
if depth dependent metrics such as total vascular length / density are reliable when compared 
at different depths within the tissue.  
No significant difference in the mean vessel segment length between the tumor types was 
observed, in agreement with the previous window-chamber observations[16]. Both the mean 
tortuosity and the fractal dimension of the vessel networks were found to be significantly higher 
for the fs120s (1.56±0.29 and 1.33±0.17 respectively) compared to the fs188s (1.33±0.13 and 
0.98±0.18 respectively). Given that there was no difference in the mean vessel segment length 
between the tumor types, a higher tortuosity for the fs120 tumors must mean that the branch 
points of the fs120 network are closer together than those of the fs188 tumors but the vessels 
themselves are more tortuous between the branchpoints. This is reflected in the fractal 
dimension measurements, with the lower value of fractal dimension for fs188s being indicative 
of a more regular, organized vessel network. This is again consistent with the previous 
observations of these tumor types with intravital microscopy, with fs120 vessels being 
described as generally wider and very chaotic in their arrangement, while fs188 vessels are 
described as regularly organized and uniformly narrow[16]. 
 
 
Fig. 10 ± The variation in quantitative vessel parameters between fs120 tumors (n=9) and fs188 
tumors (n=8) at the study endpoint. Columns: The average value of each respective quantitative 
parameter across the entire fs120 or fs188 group. (bars, standard deviation). Statistical 
significance calculated using an independent two-sample t-test between the fs120 and fs188 
datasets. 
 
 
 
 
4. Conclusions 
OCT is able to non-invasively quantify morphological differences in the superficial vasculature 
of subcutaneously implanted murine tumors expressing different VEGF isoforms, providing 
results that are consistent with those acquired by more conventional methods in previous 
studies[16]. OCT does not require the use of a transparent optical window and allows tumors 
to grow and be observed in a three-dimensional environment. Bulk-tissue-motion artefacts 
resulting from breathing or other muscular movements are effectively suppressed through a 
combination of in-plane registration, correlation optimization and combined wavelet-FFT 
filtering. Longitudinal tumor monitoring is achievable, with a high degree of vessel co-
registration between scans. However rapid variations in day-to-day vascular density are present, 
which may arise from the use of general anesthesia. This limitation could potentially be 
addressed in future through utilization of a high-speed OCT system, which may negate the 
requirements for anesthesia and physical pressure to reduce movement. This would make it 
feasible to longitudinally quantify the effects of angiogenic inhibitors or other treatments that 
directly affect the vasculature within solid tumors.  
Tumors that solely express the VEGF120 isoform were more invasive, penetrating to more 
superficial levels of the skin than the VEGF188 variants. Thinning of the hypodermis in the 
skin encapsulating both types of solid tumor leads to an improved depth penetration compared 
to healthy skin. Furthermore, disruption of the striated muscle (panniculus carnosus) layer was 
particularly common for the VEGF120 expressing tumors. Morphologically, the fs120 vessels 
appeared wider and formed dense, more disorganized networks when compared to the fs188 
vessels, which tended to form thinner more organized networks. This is evidenced by a 
significantly higher mean vessel diameter, length, tortuosity and fractal dimension for fs120 
tumors.  
The successful differentiation between these tumor types with OCT suggests that the known 
morphological differences in tumor vascularity persist outside of the window chamber model 
and are measurable without surgical intervention. Furthermore, the wound healing response to 
surgical intervention involves release of angiogenic factors such as angiopoietin-2 (Ang-2) 
from endothelial cells[31], which can compromise the use of the window chamber model in 
studies of putative anti-angiogenic therapeutics[32]. OCT has the necessary spatial resolution 
to provide an alternative and non-invasive method to quantify the vascular response of 
superficial tumors to such therapy. 
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